Summarized by Masters of Longevity from medRxiv.
A six-week feasibility RCT found KOKU-LITE was deliverable and well accepted by participants.
Key Takeaways
- Sixty community-dwelling people living with dementia were randomized.
- Retention at six weeks was 90% and consent rate was 87%.
- No serious adverse events or injurious falls were reported.
